Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
APUS · NYSE · Pharmaceutical Preparations
$1.60−0.14 (−8.05%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Apimeds Pharmaceuticals US (APUS) · oqro.io/stocks/APUS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded May 14, 2025 · Filed May 15, 2025
Chair purchased ~$14K of APUS shares in the open marketSourceInsider trade · Traded May 13, 2025 · Filed May 15, 2025
Chair purchased ~$36K of APUS shares in the open marketSourceInsider trade · Traded May 12, 2025 · Filed May 14, 2025
10% owner purchased ~$2M of APUS shares in the open marketSourceInsider trade · Traded May 12, 2025 · Filed May 14, 2025
Director purchased ~$57K of APUS shares in the open marketSource